Dextrorotation nimorazole phosphate ester

• CAT Number: I000470
• CAS Number: 1124347-33-6
• Molecular Formula: C11H19N4O7P
• Molecular Weight: 350.27
• Purity: ≥95%
• Target: Antibacterial, Antiparasitic
• Solubility: DMSO: ≥ 32 mg/mL
• Storage: 3 years -20℃ powder
• IUPAC Name: [(2R)-1-(2-methyl-5-nitroimidazol-1-yl)-3-morpholin-4-ylpropan-2-yl] dihydrogen phosphate
• InChI: InChI=1S/C11H19N4O7P/c1-9-12-6-11(15(16)17)14(9)8-10(22-23(18,19)20)7-13-2-4-21-5-3-13/h6,10H,2-5,7-8H2,1H3,(H2,18,19,20)/t10-/m1/s1
• InChIKey: CCDHHPOGWLYHAX-SNVBAGLBSA-N
• SMILES: CC1=NC=C(N1C[C@@H](CN2CCOCC2)OP(=O)(O)O)[N+](=O)[O-]

Dextrorotation Nimorazole Phosphate Ester（Cat No.:I000470）is an isotopically labeled compound used primarily in pharmaceutical research for studying the pharmacokinetics and metabolism of nimorazole. As a stereoisomer of nimorazole, it exhibits dextrorotatory optical activity, which is critical for understanding its enantiomer-specific interactions with biological targets. This compound plays a key role in investigating the ester’s absorption, distribution, metabolism, and excretion (ADME) profiles. Ideal for metabolic studies and drug development, Dextrorotation Nimorazole Phosphate Ester supports the development of targeted therapies and enhances the precision of experimental assays in clinical and laboratory settings.

Reference

[1]. Su Hongjun, Medical composition containing morpholine azomycin phosphate, its formulation and application to prepare the medical preparations as anti-anaerobic bacteria agent, antitrichomonal agent and antiamebic agent